Aprofol AG is focused on bioactive (reduced) Folates. Local or systemic folate deficiencies have a strong influence on the progression of chronic diseases. Deep knowledge of the properties of the Folate forms makes the development of promising treatments for eye disease and autism (ASD) possible.
Facts & figures
-
Type of organizationPrivate company
-
Year of foundation2013
-
Number of employees in Switzerland1-9